Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
The Journal of Clinical Psychiatry|November 15, 2023
Machine Learning Prediction of Quality of Life Improvement During Antidepressant Treatment of Patients With Major Depressive Disorder: A STAR*D and CAN-BIND-1 ReportTejas Phaterpekar, John-Jose Nunez, Emma Morton, et al.
Bjpsych Open|January 5, 2024
Functional neuroimaging biomarkers of anhedonia response to escitalopram plus adjunct aripiprazole treatment for major depressive disorderSophie R Vaccarino, Shijing Wang, Sakina J Rizvi, et al.
Psychiatry Research|April 23, 2022
Pain severity and pain interference during major depressive episodes treated with escitalopram and aripiprazole adjunctive therapy: a CAN-BIND-1 reportCalvin Diep, Norma Rosenek, Yuelee Khoo, et al.
Journal of Affective Disorders|October 28, 2021
Association between discrepancy in objective and subjective cognitive abilities and treatment response in patients with major depressive disorder: A CAN-BIND-1 study reportKaterina Rnic, Young-Eun Jung, Ivan Torres, et al.
JAMA Network Open|August 4, 2025
Latent Profile Analysis of Childhood Maltreatment and Neural Markers in DepressionJessica Rowe, Nikita Nogovitsyn, Raegan Mazurka, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 21, 2023
Relation of hippocampal volume and SGK1 gene expression to treatment remission in major depression is moderated by childhood maltreatment: A CAN-BIND-1 reportRaegan Mazurka, Simone Cunningham, Stefanie Hassel, et al.
Neuroimage. Clinical|July 20, 2025
Multi-voxel pattern analysis for characterizing functional connectivity and neurocognitive function in major depression: A CAN-BIND-1 reportAlice Rueda, Ilya Demchenko, Vanessa K Tassone, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|August 4, 2016
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological TreatmentsSidney H Kennedy, Raymond W Lam, Roger S McIntyre, et al.
Translational Psychiatry|October 11, 2024
Endocannabinoid concentrations in major depression: effects of childhood maltreatment and relation to hippocampal volumeRaegan Mazurka, Kate L Harkness, Stefanie Hassel, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|April 30, 2025
Predicting Relapse of Depressive Episodes During Maintenance Treatment: The Canadian Biomarker Integration Network in Depression (CAN-BIND) Wellness Monitoring in Major Depressive Disorder Study: Prédire la rechute d'épisodes dépressifs pendant le traitement d'entretien : Une étude de suivi du bien-être dans les troubles dépressifs majeurs du Réseau canadien d'intégration des biomarqueurs pour la dépression (CAN-BIND)Raymond W Lam, Katerina Rnic, John-Jose Nunez, et al.
Pageof 5